@article{article, title  = {{Pembrolizumab for Locally Advanced or Metastatic Urothelial Cancer Where Cisplatin is Unsuitable: An Evidence Review Group Perspective of a NICE Single Technology Appraisal}},

 url = {{http://eprints.whiterose.ac.uk/141166/ }},

 year = {{2018}},

 month = {{12}},

 author = {{Ren S and Squires H and Hock E and Kaltenthaler E and Rawdin A and Alifrangis C}},

 doi = {{10.1007/s40273-018-0750-2}},

 journal = {{PharmacoEconomics}},

 note = {{Accessed on 2024/10/22}}}